References
- Balmer, P., et al., 2007. Anti-pneumococcal antibody titre measurement: what useful information does it yield? Journal of clinical pathology, 60, 345–350.
- Black, S., et al., 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatric infectious disease journal, 19, 187–195.
- Bonilla, F.A., et al., 2005. Practice parameter for the diagnosis and management of primary immunodeficiency. Annals of allergy, asthma & immunology, 94, S1–S63.
- Bonten, M.J., et al., 2015. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. New England journal of medicine, 372, 1114–1125.
- Brandtzaeg, P., 2007. Do salivary antibodies reliably reflect both mucosal and systemic immunity? Annals of the New York academy of sciences, 1098, 288–311.
- Brown, J.S., 2012. Community-acquired pneumonia. Clinical medicine (London), 12, 538–543.
- Chiappin, S., et al., 2007. Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clinica chimica acta, 383, 30–40.
- Choo, S., et al., 2000. Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants. Journal of infectious diseases, 182, 1260–1263.
- Flanagan, K.L., et al., 2010. The challenge of assessing infant vaccine responses in resource-poor settings. Expert review of vaccines, 9, 665–674.
- Heaney, J.L., et al., 2015. Salivary functional antibody secretion is reduced in older adults: a potential mechanism of increased susceptibility to bacterial infection in the elderly. Journals of gerontology series A: biological sciences and medical sciences, 70, 1578–1585.
- Hofman, L.F., 2001. Human saliva as a diagnostic specimen. Journal of nutrition, 131, 1621S–1625S.
- Jodar, L., et al., 2003. Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine, 21, 3265–3272.
- Kauppi, M., et al., 1995. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines. Pediatric infectious disease journal, 14, 286–294.
- Mittal, S., et al., 2011. The diagnostic role of saliva – a review. Journal of clinical and experimental dentistry, 3, e314–e320.
- Nurkka, A., et al., 2001. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine. Pediatric infectious disease journal, 20, 25–33.
- Nurkka, A., et al., 2004. Salivary antibodies induced by the seven-valent PncCRM conjugate vaccine in the Finnish Otitis Media Vaccine Trial. Vaccine, 23, 298–304.
- Nurkka, A., et al., 2005. Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial. BMC infectious diseases, 5, 41.
- Oliver, S.J., et al., 2007. Salivary immunoglobulin A response at rest and after exercise following a 48 h period of fluid and/or energy restriction. British journal of nutrition, 97, 1109–1116.
- Rodenburg, G.D., et al., 2012. Salivary immune responses to the 7-valent pneumococcal conjugate vaccine in the first 2 years of life. PLoS one, 7, 16.
- Stupka, J.E., et al., 2009. Community-acquired pneumonia in elderly patients. Aging health, 5, 763–774.
- Trotter, C.L., et al., 2008. Increasing hospital admissions for pneumonia, England. Emerging infectious diseases, 14, 727–733.
- Van Nieuw Amerongen, A., et al., 2004. Salivary proteins: protective and diagnostic value in cariology? Caries research, 38, 247–253.
- Whitelegg, A.M., et al., 2012. Measurement of antibodies to pneumococcal, meningococcal and haemophilus polysaccharides, and tetanus and diphtheria toxoids using a 19-plexed assay. Journal of immunological methods, 377, 37–46.
- World Health Organization Pneumococcal conjugate vaccines, 2005. Recommendations for the production and control of pneumococcal conjugate vaccines. WHO technical report series, 927, 64–98.